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Background: West Nile virus (WNV) infection is an emerging zoonotic disease caused by an RNA virus of the genus
Flavivirus. WNV is preserved in the environment through cyclic transmission, with mosquitoes, particularly Culex
species, serving as a vector, birds as an amplifying host and humans and other mammals as dead-end hosts. To
date, no studies have been carried out to determine the prevalence of the WNV antibody in Malaysia. The aim of
this study was to screen for the seroprevalence of the WNV in Malaysia’s Orang Asli population.
Methods: Serum samples of 742 Orang Asli were collected in seven states in peninsular Malaysia. The samples
were assessed to determine the seroprevalence of WNV immunoglobulin (Ig)G with the WNV IgG enzyme-linked
immunosorbent assay (ELISA) method. For each individual, we documented the demographic factors. Anti-dengue
and anti-tick-borne encephalitis virus IgG ELISA were also performed to rule out a cross reaction. All statistical
analyses were performed using the GraphPad Prism 6 (GraphPad Software, Inc.); p values of less than 0.05 were
considered significant.
Results: The serosurvey included 298 men (40.16%) and 444 women (59.84%) of Malaysia’s Orang Asli. Anti-WNV IgG
was found in 9 of the 742 samples (1.21%). The seroprevalence was 0.67% (2 of 298) in men and 1.58% (7 of 444) in
women. The presence of anti-WNV IgG was found not to be associated with gender but, however, did correlate with
age. The peak seroprevalence was found to be 2.06% (2 of 97) in individuals between 30 to 42 years of age.
Conclusions: No previous studies have examined the seroprevalence of the WNV antibody in the human population
in Malaysia, and no clinical reports of infections have been made. Screening for the WNV seroprevalence is very
significant because of many risk factors contribute to the presence of WNV in Malaysia, such as the abundance of
Culex mosquitoes as the main vector and a high degree of biodiversity, including migratory birds that serve as a
reservoir to the virus.
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The WNV is a member of the virus family Flaviviridae,
which belongs to the Japanese encephalitis virus (JEV)
serogroup of flaviviruses and is closely associated with other
human pathogens such as dengue virus (DENV), yellow
fever virus (YFV) and tick-borne encephalitis virus (TBEV)
[1]. The flaviviruses are positive sense, single-stranded RNA
viruses [1]. Murray Valley encephalitis viruses (MVEV),
St. Louis encephalitis virus (SLEV) and Usutu virus (USUV)* Correspondence: keivan@um.edu.my
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unless otherwise stated.are also included in the JEV serogroup [1,2]. The WNV
species also contains the Kunjin virus (KUNV) subtype that
is endemic in Australia and Malaysia [3]. The flaviviruses of
the JEV serocomplex are the prominent cause of arboviral
encephalitis in vertebrate hosts, including humans [2].
Phylogenetic lineage studies show that approximately
1000 years ago, WNV emerged as a distinctive virus and
had developed into two distinct lineages [4]. Lineage 1
was found to be the source of epidemic transmission in
Africa and throughout the world, whereas lineage 2
was discovered in horses in sub-Saharan Africa and
Madagascar [5]. The West Nile virus was first isolated in a
woman in the West Nile district of Uganda in 1937 [6].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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occurred in 1999 in New York City [6,7], apparently by
transference from infected humans, birds or mosquitoes
[8]. This emergence of WNV in North America marked
the first time that this virus had been identified outside
the Eastern Hemisphere [9]. It appears clear that the
source of the WNV strain detected in New York City
originated in the Middle East [10].
In 1957, in an outbreak amongst aged patients in Israel,
the virus was recognized as a cause of severe human
meningitis or encephalitis (inflammation of the brain and
spinal cord) [7]. It was usually related with asymptomatic,
self-limiting childhood infections in humans [11]. Since
then, the disease has spread through much of the world
including Africa, Europe, the Middle East, central Asia and
recently, North America. It has been detected in humans,
animals and mosquitoes in all of these regions [11]. In
2000, the epizootic extended to 12 states and the District of
Columbia [12], and WNV can now be found in many avian
and mosquito species throughout North America [13,14].
From 1999 to 2010, more than 2.5 million people were
infected, with over 12,000 reported cases of encephalitis or
meningitis and over 1,300 deaths [15].
The presentation of clinical illness in humans ranges
from asymptomatic infection to viral syndrome to
neurologic disease [16]. In the epidemic of WNV infection,
it is estimated that 80% of infections are asymptomatic and
the other 20% present as a dengue-like viral syndrome with
fever, headache, body aches and sometimes a skin rash on
the trunk and swollen lymph glands [17]. It can be severe
but is commonly self-limited, and less than 1% of cases lead
to neuroinvasive disease such as encephalitis, meningitis or
polio-like flaccid paralysis [16]. The incubation period may
be as short as 2 days or as long as 14 days, and the
mortality rate ranges from 4% to 15%, whereas patients
with encephalitis and flaccid paralysis have a poorer
prognosis [18].
WNV is a mosquito-borne flavivirus transmitted to
humans by mosquitoes, primarily the Culex genus, in
particular Culex pipiens that serve as a vector, birds that
serve as intensifying hosts and humans or others mammals
that serve as dead-end hosts [19-21]. Zoonotic WNV circu-
lates in natural transmission cycles comprising mosquitoes
and birds and a range of other vertebrates, such as horses
and humans, are incidental hosts. WNV is maintained in
mosquito populations through vertical transmission (adults
to eggs); birds are an important reservoir of WNV in the
environment; more than 200 species of birds in the United
States were found to be infected [22]. Studies have shown
that transmission between birds in the absence of mosqui-
toes can occur in a laboratory setting; however it is
unknown whether this would be the case in the natural
environment [22]. In prominent of dynamics pathogen
transmission, the ecology activities of hosts can play animportant role [23]. Host searching ecology, habitat affec-
tion and social communication are able to manipulate the
possibility of contact with an infected host or the environ-
ment and thus construct hotspot of transmission [23-25].
Many species of vertebrates can be infected by these virus-
carrying mosquitoes, including horses, which have a high
mortality rate [26]. Humans usually experience a low level
of viremia; however, transmission through organ trans-
plantation and blood transfusion has been recorded [26]. A
case of transmission through breastfeeding was reported,
but the infant remained asymptomatic [26].
At present, no studies have been carried out in Malaysia
regarding the seroprevalence of the WNV antibody in the
human population, and no clinical reports of infections
have been made. This could be due to undiagnosed or
misdiagnosed subclinical infections or because the WNV
has not yet reached Malaysia. The objective of this study
was to screen for the prevalence of antibodies against
WNV, particularly immunoglobulin (Ig)G, among Malaysia’s
Orang Asli, the native people, who make up less than 1%
of the Malaysian population. Most of them reside at the
frontier of the jungle and rural areas (61%) and in the
center of the jungle (37%), and only a small number of
them are found in or close to an urban area (1%). Because
dengue fever is endemic in Malaysia, a comparison with
the anti-dengue IgG antibody result is also discussed to
rule out cross reactivity.
Methods
Ethics statement
The study acknowledged distinctive consent from the
Department of Orang Asli Development (JAKOA) and
attained approval from the Ethics Committee of the
University Malaya Medical Centre (UMMC) (MEC
Ref.824.11). Contribution in this study was virtuously
voluntary. The volunteers were given a briefing on the
project and were allowed adequate time for consideration.
Written informed consent was acquired. An additional
agreement form was completed by the parents or guardian
of volunteers below legal age (less than 18 years old). The
samples were prepared with rigid obscurity. All volunteers
had completed a given questionnaire to identify symptoms
they had experienced and their lifestyle. All volunteers
gave written consent for the use of blood samples after
the samples were made anonymous.
Sample collection
All blood samples were collected between September
2012 and February 2013 from 742 Orang Asli from seven
states in peninsular Malaysia (Perak, Melaka, Pahang,
Negeri Sembilan, Kelantan, Selangor and Johor states)
with the assistance of a proficient medical assistant. Most
of the Orang Asli were forest inhabitants. They were inter-
viewed and given a standard questionnaire regarding
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Anti-WNV serology
WNV IgG testing was done by WNV IgG capture
DxSelectTMELISA (Focus Diagnostics, Cypress, USA)
according to the manufacturer’s instructions [5,27,28].
The serum samples were also tested for the presence of
IgM of tick-borne encephalitis virus (TBEV) and dengue
virus (DENV) —flaviviruses commonly found in Malaysia
— so as to rule out cross reactivity. In this assay, polystyr-
ene microwells were coated with recombinant WNV
antigen. The tests were performed according to the manu-
facturer’s instructions. According to the manufacturer, the
sensitivity was determined with the samples with expected
positivity for IgG anti-WNV (vaccinated for flaviviruses or
persons with past WNV infection). Serum samples were
taken from the unvaccinated blood samples.
Statistical analysis
Categorical data were assessed in two-way contingency
table analyses using Fisher’s exact test. The correlation ofFigure 1 Reactive serum of WNV in Peninsular Malaysia. The figure ind
Orang Asli collected throughout the study site in peninsular Malaysia.age and reactivity of WNV infection were determined by
means of the Spearman nonparametric correlation. All
statistical analyses were performed using GraphPad Prism
6 (GraphPad Software, Inc.), and p values of less than 0.05
were considered significant.
Results
An overview of the characteristics of the 742 serum
samples are shown in Figure 1 (listed by state in Malaysia)
and Table 1 (listed by age and gender). The study panel
included 298 male volunteers with a median age of 13 and
444 female volunteers with a median age of 20.Overall,
ages ranged from 3 to 90 years, with a median of 17. A
total of 370 volunteers (49.86%) were 17 years or younger,
and 372 volunteers (50.13%) were 17 years and older.
Analysis by state indicated that Pahang had the highest
percentage of reactivity to the anti-WNV IgG enzyme-
linked immunosorbent assay (ELISA) test (5.93%), and five
states (Selangor, Johor, Melaka, Kelantan and Perak) did
not show the presence of WNV.
In general, anti-WNV IgG was discovered in 9 of 742
samples (1.21%). There was no significant difference inicated the distribution of reactive serum of WNV from the Malaysia’s
Table 1 Seroprevalence of WNV according to age
GENERAL PROFILE SEROPOSITIVE SERONEGATIVE TOTAL % (95% CI)
GENDER
MALE 2 296 298 0.67 (0.0002-0.0258)
FEMALE 7 437 444 1.6 (0.0070-0.0329)
AGE (YEARS)
≤16 4 360 364 1.1 (0.0030-0.0282)
17 to 29 2 169 171 1.18 (0.0005-0.0449)
30 to 42 2 97 99 2.06 (0.0012-0.0766)
43 to 55 1 63 64 1.58 (<0.0001-0.0927)
56 to 68 0 33 33 0 (0.00-0.1239)
≥69 0 11 11 0 (0.00-0.3002)
Table showed the seroprevalence of WNV following to the age-group among the Malaysia’s Orang Asli.
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dence interval [CI], 0.0002 to 0.0258) and female (1.58%;
95% CI, 0.0070 to 0.0329; P = 0.3270) groups (Table 1).
The highest rates of reactivity to anti-WNV IgG ELISA
were 3.13% (95% CI, <0.0001 to 0.1711) for men between
43 and 55 years age and 2.74% (95% CI, 0.0018 to 0.1002)
for women between 30 and 42 years of age (P = 1.000). A
summary of serum prevalence by age and gender is
presented in Table 2. At least 86 of the 742 samples
(11.59%) exhibited cross-reactivity for anti-TBEV IgG and
1 of 742 (0.13%) for anti-dengue IgG, whereas 14 of the
742 samples (1.89%) were found to have cross-reactivity
for all three types of viruses (Table 3). The study also
showed that there was no significant difference regarding
antibody prevalence and gender (Fisher’s exact test,
P = 0.3270). The seroprevalence was 0.67% (2 of 298) in
male subjects and 1.58% (7 of 444) in female subjects
(Figure 2). However, as illustrated in Figure 3, the different
age groups were associated with reactivity of the sample
(P = 0.0028) (Spearman, r = −0.9710).
Discussion
To date, no studies have been carried out in Malaysia
regarding the seroprevalence of the WNV antibody in the
human population, and no clinical reports of infections
have been made. Screening for WNV seroprevalence is
necessary and important because of many risk factors for




17 to 29 1 47
30 to 42 0 26
43 to 55 1 31
56 to 68 0 14
≥69 0 4
TOTAL 298
Table presented the summary of prevalence serum of WNV regards to both age anof Culex mosquitoes as the main vector and the appropri-
ate climatic situation for the propagation of mosquitoes
and migratory birds that serve as a reservoir for the virus
[29]. This assertion was supported by a study that showed
Culex mosquitoes are abundantly distributed across the
states of Malaysia [30]. Moreover, preceding study on the
behavior of host such as their nocturnal roosting patterns
is significantly important in WNV transmission [23]. This
natural behavior is expected to affect the contact rates
with hunting mosquitoes. The abundance of host-seeking
Culex mosquitoes may be higher in the forest canopy [25]
so birds roosting may be visible to more mosquito bite
[23]. In addition, previous study was done in north-
western Italy proved that precipitation and warm
temperature is strongly related to the WNV transmission
[31]. Even though, the warm temperature does put in the
diverge effect on vector competence, still it does influence
in the abundance of adult mosquitoes and thus providing
more potential vectors for WNV [32].
This study is the first such to be conducted in Malaysia.
We screened 742 serum samples from Malaysia’s Orang
Asli from seven states in peninsular Malaysia, and the
results suggest that WNV has a low prevalence in Malaysia
(1.21%, or 7 of 742). Although it is not considered endemic,
a prolonged study should be done. In 2011, a study con-
ducted among captive birds to determine the presence of
the WNV antibody was carried out in four selected areas in









d gender of Malaysia’s Orang Asli.
Table 3 Cross-reactivity of WNV against TBEV, DENV and
all three types of viruses
TBEV (%) DENV (%) TBEV AND DENV (%)
SEROPOSITIVE 11.59 0.13 1.89
SERONEGATIVE 88.41 99.87 98.11
Table presented the exhibited cross-reactivity of WNV for TBEV, DENV and for
all three types of viruses.
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mosquitoes are their principal vertebrate and vector hosts,
respectively, and all are spread by migratory birds [20]. It is
believed that birds infected with more virulent epidemic
strains of the virus are too sick to migrate; thus, only birds
infected with less virulent viral strains can make the long
journey [20]. As for WNV vector competence, hybrid
populations of Culex species mosquitoes produced from
cross mating lines exhibited that hybridization has signifi-
cant impact on WNV infection [34], dissemination and
transmission which could be due to the environmental or
anthropogenic changes [35].
We discovered that the cross-reactivity in IgG anti-
bodies of WNV and DENV (0.13%) was lower than with
TBEV (11.59%) [36]. The lower percentage of DENV IgG
antibodies obtained from the serosurvey suggested that
most of the Orang Asli people were less infected with
WNV and DENV, though DENV is consider to be
endemic in Malaysia compared to TBEV, because Aedes
aegypti and Culex pipiens are the main vector for DENV
and WNV, respectively, which can be found abundantly in
rural areas but not in the forest [37,38]. This could have
an effect on the seroreactivity of the samples because the
volunteers were forest-dwellers.
Due to some limitation in this study, neutralisation tests
were not executed for the confirmation of positive WNV
antibodies by ELISA tests. According to the previous
study, patients with positive WNV infection by ELISA
were also confirmed to be positive by neutralisation tests
[4]. The WNV IgG resulted by an ELISA is a dependable99.33%
1.58%0.67%
Figure 2 Reactivity of WNV towards gender. The figure presented that t
of the WNV.marker of the presence of neutralizing antibodies against
WNV when assuming the absence of previous history of
other flavivirus vaccinations or infections in an individual.
The ELISA fulfilled the necessities of this study, since the
main objective was to determine the prevalence of WNV
IgG among the Malaysia’s Orang Asli population, even
though the risk that the subjects either had susceptibility
or were indicating cross-reactive antibodies and consider-
ing the likelihood that the virus had been blank from the
blood at the time the samples have been engaged.
Because there was doubt about cross-reactivity with other
viruses, the IgG ELISA test was performed on two other
flaviviruses, TBEV and dengue virus. However, only 86 of
742 samples (11.59%) exhibited cross-reactivity for anti-
TBEV IgG and only 1 of 742 samples (0.13%) for anti-
dengue IgG, whereas 14 of the 742 samples (1.89%) were
found to have cross-reactivity for all three types of viruses.
Another study showed that the seropositivity of WNV
did not correlate with age and gender [4], nevertheless we
found that age did correlate with the incidence of WNV
infection; the highest rate of reactive serum samples was
in the adult age group between 30 and 42 years of age,
likely because people from this age group participate in a
lot of outdoor activities such as hunting and working in
the forest. Furthermore, there were fewer volunteers of
50 years and above of age in our study compared to other
age groups. Moreover, in another study, it was found that
seropositive persons were likely to be older than seronega-
tive ones, but that age did not persist as an autonomous
risk factor for the infection [5].
Although WNV is not endemic, our study demonstrates
that the presence of WNV in several states in peninsular
Malaysia could be an early warning of transmission of the
virus. Transmission of the virus will be very difficult to
prevent and control because the public health infrastruc-
ture is insufficient to cope with vector-borne and zoonotic
diseases [20]. In the absence of a specific treatment or
vaccine, efforts at preventing transmission should focus98.42%
here is no correlation between the gender and the reactivity of samples

























Figure 3 Reactivity of WNV towards age. The figure shows the correlation between the age group and the reactivity of samples of the WNV.
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is deserving of further study, as this is the first study to
ascertain the presence of antibodies against WNV in
Malaysia’s Orang Asli.
Conclusions
No previous studies have examined the seroprevalence of
the WNV antibody in the human population in Malaysia,
and no clinical reports of infections have been made.
Screening for the WNV seroprevalence is very significant
because many risk factors contribute to the presence of
WNV in Malaysia, such as the abundance of Culex
mosquitoes as the main vector and a high degree of
biodiversity, including migratory birds that serve as a
reservoir to the virus.
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